Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session on Growth Update - Case Based Approach to short stature
A case-based approach to managing short stature provides a comprehensive framework for understanding and addressing the condition in pediatric patients. Short stature, defined as a height significantly below the average for a child's age and sex, can be caused by a variety of genetic, hormonal, and environmental factors. This approach involves detailed case evaluations to identify the underlying causes and determine the most appropriate interventions.
The first step in a case-based approach is a thorough evaluation of the patient’s medical history, growth patterns, and physical examination findings. Key assessments include growth charts, familial height patterns, and screening for chronic illnesses or nutritional deficiencies. Hormonal evaluations and genetic testing may also be necessary to pinpoint specific causes, such as growth hormone deficiencies or genetic syndromes.
Tailored treatment plans ensure that each patient receives the most effective and targeted intervention based on their unique condition and needs.
Therefore, get an overall knowledge of growth update - case based approach to short stature
See More Webinars @ Hidoc Webinars
1.
Belgian Algorithm Reshapes Endometrial Cancer Care
2.
ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer
3.
Nuclear missile workers are contracting cancer: They blame the bases
4.
On all CAR-T products, the FDA is calling for a new boxed warning.
5.
ASCO Future Focus: Metastatic Breast Cancer: Future Focus from the American Society of Clinical Oncology
1.
Understanding SVR Normal Range: A Guide to Achieving Optimal Health
2.
Consensus Recommendations for Healthy Hematologic Aging
3.
The Role of Alanine Aminotransferase in Liver Health and Disease
4.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
5.
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation